Andreas Jeromin
Company: New Diagnostic Company emerging from Stealth Mode
Job title: Chief Scientific Officer
Seminars:
Scaling CNS Therapeutics: Rethinking Diagnosis, Delivery & Reimbursement in the Future of a Fragmented System 12:00 pm
Why underdiagnosis, long wait times, and neurologist shortages restrict access and how CNS therapeutics include the reliance on costly measurement devices (e.g. MRI / PET scans) and the lack of access to such devices at many clinical sites What a scalable CNS care model must include: new clinical networks, broader education efforts, and the crucial…Read more
day: Conference Day Two
Chair’s Opening Remarks 8:25 am
day: Conference Day One